Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
Condition(s):Uncomplicated Plasmodium Falciparum MalariaLast Updated:February 29, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Uncomplicated Plasmodium Falciparum MalariaLast Updated:February 29, 2024Recruiting
Condition(s):MalariaLast Updated:March 6, 2024Not yet recruiting
Condition(s):MalariaLast Updated:March 27, 2024Recruiting
Condition(s):Malaria in Pregnancy; Pregnancy Related; Congenital AnomalyLast Updated:April 1, 2021Recruiting
Condition(s):Subacute Cutaneous Lupus Erythematosus; Chronic Cutaneous Lupus ErythematosusLast Updated:March 28, 2024Recruiting
Condition(s):Malaria; Malaria,FalciparumLast Updated:August 7, 2023Recruiting
Condition(s):Malaria,Falciparum; Malaria in Pregnancy; MalariaLast Updated:December 12, 2023Recruiting
Condition(s):Malaria,FalciparumLast Updated:May 9, 2023Recruiting
Condition(s):Plasmodium Falciparum Malaria (Uncomplicated)Last Updated:March 27, 2024Recruiting
Condition(s):MalariaLast Updated:September 1, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.